AIDS Treatment News
Table of Contents, February 23, 2001

• Tenofovir DF Expanded Access
  An important new drug is now available through a special program for patients with advanced AIDS who have failed approved therapies.

• New Immune-Based Treatment Approach: Trial Recruiting in San Francisco
  A clinical trial of a new kind of immune-based treatment -- using a drug widely available in Japan for other purposes -- is now recruiting in San Francisco.

• Africa Access: Moving Fast, Outcome Uncertain
  In many developing countries fewer than one in a thousand persons with HIV receive modern treatment, mainly because they cannot pay for the drugs, which are often sold at rich-country prices although they cost little to manufacture. Affordable treatments are clearly possible, but have been held back for years due to pharmaceutical companies' fears over patent protection. Now there is intense interest in finding solutions, and several possible approaches are on the table.
  Advertisement

• South Africa Lawsuit: March 5 Worldwide Protest Information
  For three years some the world's largest pharmaceutical companies have been suing South Africa to stop implementation of its post-apartheid medicine reform law; the case is scheduled to go to trial March 5. Solidarity protests are planned for that date in Australia, Brazil, Canada, France, Germany, Italy, Philippines, South Africa, Thailand, United Kingdom, the United States, and probably elsewhere as well.

• AIDS Treatment News Publication Schedule, February-March 2001
  

ISSN # 1052-4207

Copyright 2001 by John S. James. Permission granted for noncommercial reproduction, provided that our address and phone number are included if more than short quotations are used.